Samsung Biologics Co.,Ltd. (207940.KS)
KRW 959000.0
(-2.14%)
KRW 959000.0
(-2.14%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 12.05 Thousand KRW | 5.31% |
| 2022 | 11.44 Thousand KRW | 94.39% |
| 2021 | 5886.12 KRW | 63.33% |
| 2020 | 3603.77 KRW | 18.76% |
| 2019 | 3034.43 KRW | -9.46% |
| 2018 | 3351.55 KRW | 331.05% |
| 2017 | -1450.60 KRW | 52.94% |
| 2016 | -3082.32 KRW | -108.02% |
| 2015 | 38.42 Thousand KRW | 790.76% |
| 2014 | -5561.96 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 4467.81 KRW | 77.29% |
| 2024 Q3 | 3715.80 KRW | -16.83% |
| 2024 Q1 | 2520.05 KRW | -38.3% |
| 2023 Q1 | 1991.67 KRW | -61.68% |
| 2023 Q3 | 3377.17 KRW | 30.01% |
| 2023 Q2 | 2597.66 KRW | 30.43% |
| 2023 Q4 | 4084.13 KRW | 20.93% |
| 2023 FY | - KRW | 5.31% |
| 2022 Q2 | 2160.00 KRW | -2.75% |
| 2022 FY | - KRW | 94.39% |
| 2022 Q4 | 5197.25 KRW | 186.35% |
| 2022 Q3 | 1815.00 KRW | -15.97% |
| 2022 Q1 | 2221.00 KRW | 85.23% |
| 2021 Q2 | 1817.71 KRW | 99.24% |
| 2021 FY | - KRW | 63.33% |
| 2021 Q4 | 1199.04 KRW | -39.17% |
| 2021 Q3 | 1971.08 KRW | 8.44% |
| 2021 Q1 | 912.32 KRW | -37.27% |
| 2020 Q4 | 1454.27 KRW | 73.32% |
| 2020 Q3 | 839.09 KRW | 7.89% |
| 2020 Q1 | 548.18 KRW | -82.78% |
| 2020 FY | - KRW | 18.76% |
| 2020 Q2 | 777.74 KRW | 41.88% |
| 2019 Q1 | -574.90 KRW | -111.99% |
| 2019 FY | - KRW | -9.46% |
| 2019 Q4 | 3183.28 KRW | 382.32% |
| 2019 Q3 | 659.99 KRW | 428.57% |
| 2019 Q2 | -200.87 KRW | 65.06% |
| 2018 Q2 | -291.90 KRW | 58.16% |
| 2018 FY | - KRW | 331.05% |
| 2018 Q4 | 4795.31 KRW | 1287.81% |
| 2018 Q3 | -403.71 KRW | -38.3% |
| 2018 Q1 | -697.60 KRW | -356.96% |
| 2017 Q4 | -152.66 KRW | 67.79% |
| 2017 Q1 | -494.75 KRW | 52.13% |
| 2017 FY | - KRW | 52.94% |
| 2017 Q2 | -330.49 KRW | 33.2% |
| 2017 Q3 | -473.97 KRW | -43.41% |
| 2016 Q3 | -791.60 KRW | 11.8% |
| 2016 Q2 | -897.47 KRW | -94.63% |
| 2016 Q4 | -1033.55 KRW | -30.56% |
| 2016 Q1 | -461.11 KRW | 0.0% |
| 2016 FY | - KRW | -108.02% |
| 2015 FY | - KRW | 790.76% |
| 2014 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ORIENT BIO Inc. | 108.55 KRW | -11000.875% |
| Green Cross Holdings Corporation | -1210.00 KRW | 1095.868% |
| Green Cross Holdings Corporation | -2333.42 KRW | 616.409% |
| Pharmicell Co., Ltd. | 60.00 KRW | -19983.333% |
| Green Cross Corporation | -2333.42 KRW | 616.409% |
| GeneOne Life Science, Inc. | -1000.23 KRW | 1304.723% |
| Celltrion, Inc. | 3759.00 KRW | -220.564% |
| SK bioscience Co.,Ltd. | 291.00 KRW | -4040.893% |
| SK Biopharmaceuticals Co., Ltd. | -419.89 KRW | 2969.799% |
| Prestige BioPharma Limited | -547.81 KRW | 2299.668% |